Corrigendum to: Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French Vasculitis Study Group

Rheumatology (Oxford). 2020 Sep 1;59(9):2653. doi: 10.1093/rheumatology/kez688.

Antoine Lafarge^{1

2}, Adrien Joseph³, Christian Pagnoux⁴, Xavier Puéchal^{1

2}, Pascal Cohen^{1

2}, Maxime Samson⁵, Mohamed Hamidou⁶, Alexandre Karras⁷, Thomas Quemeneur⁸, Camillo Ribi⁹, Matthieu Groh¹, Luc Mouthon^{1

2

10}, Loïc Guillevin^{1

2

10}, Benjamin Terrier^{1

2

10}; French Vasculitis Study Group (FVSG)

¹ Department of Internal Medicine.
² National Referral Center for Rare Systemic Autoimmune Diseases, Cochin Hospital.
³ INSERM, U1138, Paris, France.
⁴ Department of Rheumatology, Mount Sinai Hospital, Toronto, ON, Canada.
⁵ Department of Internal Medicine and Clinical Immunology, Hôpital François Mitterrand, Dijon.
⁶ Department of Internal Medicine, Hôtel Dieu, Nantes.
⁷ Department of Nephrology, Hôpital Européen Georges Pompidou, Paris.
⁸ Department of Internal Medicine, Hôpital de Valenciennes, Valenciennes, France.
⁹ Department of Immunology, CHUV, Lausanne, Switzerland.
¹⁰ Paris Descartes University, Paris 5, Paris, France.

No abstract available

Publication types